Pfizer Inc (PFE) |
|
38.18 0.75 (2%)
|
10-24 22:50 |
|
Open: |
37.93 |
Pre. Close: |
37.43 |
|
High:
|
38.285 |
Low:
|
37.6474 |
|
Volume:
|
25,230,908 |
Market Cap:
|
212,162M |
|
|
|
|
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. The company is headquartered in New York City, New York and currently employs 92,400 full-time employees. The firm is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The firm manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
38.345 - 38.528 |
38.528 - 38.695 |
|
Low:
|
37.192 - 37.408 |
37.408 - 37.605 |
|
Close:
|
37.825 - 38.179 |
38.179 - 38.501 |
|
Technical analysis |
as of: 2020-10-23 4:47:47 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 45.38 One year: 53.00 |
| Support: |
Support1: 36.71 Support2: 35.38 |
| Resistance: |
Resistance1: 38.85 Resistance2: 45.38 |
| Pivot: |
37.08 |
| Moving Average: |
MA(5): 37.60 MA(20): 36.91
MA(100): 36.36 MA(250): 36.63 |
| MACD: |
MACD(12,26): 0.26 Signal(9): 0.12 |
| Stochastic oscillator: |
%K(14,3): 54.37 %D(3): 50.39  |
| RSI: |
RSI(14): 62.10 |
| 52-week: |
High: 40.97 Low: 27.88 Change(%): 2.4 |
| Average Vol(K): |
3-Month: 2217898 10-Days: 2288025 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.PFE has closed below upper band by 0.3%. Bollinger Bands are 30.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 23 Oct 2020
Pfizer Inc. (PFE) Closes 2% Up on the Day for October 23 - Equities.com
Fri, 23 Oct 2020
Pfizer Inc (PFE) 3 Day Down Streak Broken; in an Uptrend Over Past 14 Days - CFD Trading
Thu, 22 Oct 2020
Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a vaccine is available - Times of India
Thu, 22 Oct 2020
Big Few Weeks Ahead for Pfizer Stock - Schaeffers Research
Wed, 21 Oct 2020
Reasons Why Long-term Faith on Pfizer Inc. (PFE) Could Pay Off Investors - The InvestChronicle
Tue, 20 Oct 2020
Were Hedge Funds Right About Pfizer Inc. (PFE)? - Yahoo Finance
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers General |
| Shares Out. (M) |
5,560 |
| Shares Float (M) |
5,550 |
|
% Held by Insiders
|
0.04 |
|
% Held by Institutions
|
72.56 |
|
Shares Short (K)
|
42,750 |
|
Shares Short P. Month (K)
|
50,220 |
Stock Financials |
|
EPS
|
2.530 |
|
EPS Est This Year
|
2.560 |
|
EPS Est Next Year
|
2.760 |
|
Book Value (p.s.)
|
11.580 |
|
Profit Margin
|
28.81 |
|
Operating Margin
|
29.82 |
|
Return on Assets (ttm)
|
5.5 |
|
Return on Equity (ttm)
|
22.8 |
|
Qtrly Rev. Growth
|
-11.0 |
|
Gross Profit (p.s.)
|
7.507 |
|
Sales Per Share
|
8.849 |
|
EBITDA (p.s.)
|
3.606 |
|
Qtrly Earnings Growth
|
-32.10 |
|
Operating Cash Flow (M)
|
14,970 |
|
Levered Free Cash Flow (M)
|
9,250 |
Stock Valuations |
|
PE Ratio
|
15.09 |
|
PEG Ratio
|
2.41 |
|
Price to Book value
|
3.30 |
|
Price to Sales
|
4.31 |
|
Price to Cash Flow
|
14.18 |
Stock Dividends |
|
Dividend
|
1.480 |
|
Forward Dividend
|
1.520 |
|
Dividend Yield
|
0.04 |
|
Dividend Pay Date
|
2020-11-30 |
|
Ex-Dividend Date
|
2020-11-04 |
|
7 Binary Options
|
|
Your Ad Here
|
|
